Editorial: miRNAs and their role in endocrine cancer progression: from prognosis to treatment

Prem Prakash Kushwaha; Francesco Doglietto; Gianluca Baldanzi

doi:10.3389/fendo.2023.1257692

Editorial: miRNAs and their role in endocrine cancer progression: from prognosis to treatment

Front Endocrinol (Lausanne). 2023 Aug 18:14:1257692. doi: 10.3389/fendo.2023.1257692. eCollection 2023.

Authors

Prem Prakash Kushwaha¹, Francesco Doglietto^{2

3}, Gianluca Baldanzi^{4

5}

Affiliations

¹ School of Medicine, Case Western Reserve University, Cleveland, OH, United States.
² Neurosurgery, Università Cattolica del Sacro Cuore, Rome, Italy.
³ Neurosurgery, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
⁴ Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
⁵ Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), University of Piemonte Orientale, Novara, Italy.

No abstract available

Keywords: biomarker; gene expression; gene silencing; interfering RNA; oncology; post-transcriptional regulation.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Endocrine Gland Neoplasms*
Humans
MicroRNAs* / genetics
Neoplasms*
Neoplastic Processes
Prognosis

Substances

MicroRNAs

Grants and funding

GB is supported by the Italian Ministry of Education, University, and Research Program PRIN 2017 (grant 201799WCRH) and the FAR-2019, Italian Ministry of University and Research Program “Departments of Excellence 2018-2022”, AGING Project, Department of Translational Medicine, Università del Piemonte Orientale Novara, Italy.